Benefits of Retention in Methadone Maintenance and Chronic Medical Conditions as Risk Factors for Premature Death Among Older Heroin Addicts

Fareed, Ayman; Casarella, Jennifer; Amar, Richard; Vayalapalli, Sreedevi; Drexler, Karen

doi:10.1097/01.pra.0000351884.83377.e2

Cited by 91 publications

(74 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Fareed et al (2009) (III) conducted a retrospective chart review of older patients enrolled in a methadone maintenance programme. Patients who remained in treatment showed statistically significant improvements in drug use, psychiatric, medical and legal problems.…”

Section: Opioidsmentioning

confidence: 99%

BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP

Welch²,

et al. 2012

View full text Add to dashboard Cite

The British Association for Psychopharmacology guidelines for the treatment of substance abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on their pharmacological management. They are based explicitly on the available evidence and presented as recommendations to aid clinical decision making for practitioners alongside a detailed review of the evidence. A consensus meeting, involving experts in the treatment of these disorders, reviewed key areas and considered the strength of the evidence and clinical implications. The guidelines were drawn up after feedback from participants. The guidelines primarily cover the pharmacological management of withdrawal, short-and long-term substitution, maintenance of abstinence and prevention of complications, where appropriate, for substance abuse or harmful use or addiction as well management in pregnancy, comorbidity with psychiatric disorders and in younger and older people. KeywordsSubstance misuse, addiction, guidelines, pharmacotherapy, comorbidity 1 Imperial College London, CNWL NHS Foundation Trust, London, UK 2 Gether NHS Foundation Trust, Gloucester, UK 3 Pennine Care NHS Foundation Trust, Ashton-under-Lyne, UKOther invited participants at the consensus meeting who contributed to the discussion and commented on the guidelines were Drummond C, Farrell M, Gilvarry E, Strang J. John, a user representative, read and commented on the written guidelines. Prof W van den Brink reviewed the written guidelines.

show abstract

Section: Opioidsmentioning

confidence: 99%

BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP

Welch²,

et al. 2012

View full text Add to dashboard Cite

show abstract

“…On average, the conventional group stress-related interventions that were rated highest and lowest in terms of treatment willingness and perceived efficacy were nutrition or advice about healthy food choices and anger management, respectively. Previous research has documented the high prevalence of nutrition-related medical conditions and problems among MMT patients, including deficits in nutrition, obesity, diabetes, hypertension, and hyperlipidemia, and the beneficial changes in diet, weight, and blood lipids following brief nutritional counseling and in consumption of saturated fats, fruits and vegetables following more intense counseling interventions (Mohs et al, 1990;Ockene et al, 1999;Pignone et al, 2003;Fareed et al, 2009;Gosnell & Levine, 2009). The frequent co-occurrence of obesity and substance use disorders has led to recent calls for treatment approaches that address both (See (VanBuskirk & Potenza, 2010)).…”

Section: Discussionmentioning

confidence: 99%

Group-Based Strategies for Stress Reduction in Methadone Maintenance Treatment: What Do Patients Want?

Barry¹,

Beitel²,

Breuer³

et al. 2010

Journal of Addiction Medicine

View full text Add to dashboard Cite

Objectives-To assess methadone maintenance treatment (MMT) patients' willingness to use, and perceived efficacy of, conventional and unconventional group stress reduction treatments Methods-A survey, developed by the authors, was administered to 150 MMT patients.Results-Levels of treatment willingness and perceived efficacy for both conventional and unconventional treatments were relatively high; however, ratings for conventional interventions were, on average, significantly higher than those for unconventional ones. The highest rated conventional and unconventional treatments in terms of willingness and perceived efficacy were nutrition and spiritual counseling, respectively, while the lowest rated conventional and unconventional group treatments were anger management and visualization training, respectively. White race was a significant predictor of lower willingness to try conventional and unconventional group therapies and lower perceived efficacy of unconventional group treatment, while female sex and older age were significant predictors of higher levels of willingness to try unconventional group treatment. Higher levels of substance use problems were associated with increased willingness to try conventional group treatment. Higher levels of anxiety emerged as a significant independent predictor of treatment willingness and perceived efficacy for both conventional and unconventional group treatments.Conclusions-The relatively high levels of treatment willingness and perceived efficacy of conventional and unconventional group stress reduction treatments point to the feasibility of offering these interventions in MMT and suggest that in particular high levels of anxiety are associated with greater treatment willingness and perceived treatment efficacy.

show abstract

“…Status Report supported the finding that the percentage of patients infected with hepatitis C also went up (from 42% to 56%). Among the older group the reported worldwide incidence of liver cirrhosis was 14% , hepatitis C varied between 24% and 82% (Fareed, Casarella, Amar, Vayalapalli, & Drexler, 2009;Lofwall et al, 2005;Rosen et al, 2008), and incidence of liver disease ranged between 11% and 18% (Firoz & Carlson, 2004;Novick et al, 1993).…”

Section: Physical Healthmentioning

confidence: 99%

“…Somatic problems with lung diseases described among the older group were chronic lung disease 22% ) and respiratory problems 33% (Beynon et al, 2009). The prevalence of chronic obstructive pulmonary disease (COPD) varied between 9% and 16% (Fareed et al, 2009;Novick et al, 1993) and the incidence of asthma between 4% and 10% (Firoz & Carlson, 2004;Lofwall et al, 2005;Novick et al, 1993).…”

Section: Physical Healthmentioning

confidence: 99%

Health and social issues among older patients in opioid maintenance treatment in Norway

Gaulen

Alpers

Carlsen

et al. 2017

Nordic Studies on Alcohol and Drugs

View full text Add to dashboard Cite

In 2015 the Ministry of Health and Care Services was revising the National Action Plan for drug treatment and rehabilitation in Norway. Connected to this, Alcohol and Drug Research Western Norway (KORFOR) examined the health and social issues for older patients with substance-use disorder (SUD) and the possible challenges for the healthcare services. The report to the ministry (KORFOR, 2015) was divided into two general areas: the elderly and alcohol, and the elderly in opioid maintenance treatment (OMT). The report sought to answer the following questions: Which social and health issues do these two groups struggle with? How are the support services for these groups organised and developed, both in the municipalities and the specialist health services? What consequences may an increased number of the elderly in these groups have for the need to increase capacity and to change services?

show abstract

Benefits of Retention in Methadone Maintenance and Chronic Medical Conditions as Risk Factors for Premature Death Among Older Heroin Addicts

Abstract: The results presented here suggest potential targets for intervention related to lifestyle risk factors and comorbid medical conditions, such as nicotine dependence and diabetes mellitus, that may have the potential to improve health outcomes for older patients with opioid dependence.

Cited by 91 publications

References 36 publications

BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP

BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP

Group-Based Strategies for Stress Reduction in Methadone Maintenance Treatment: What Do Patients Want?

Health and social issues among older patients in opioid maintenance treatment in Norway

Contact Info

Product

Resources

About